Clinical Trials Directory

Trials / Completed

CompletedNCT01806363

Pharmacokinetic Interactions and Safety Study of Telmisartan and Chlorthalidone

A Phase I Clinical Trial to Evaluate the Pharmacokinetic Interactions and Safety Between Telmisartan and Chlorthalidone in Healthy Male Volunteers.

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
HanAll BioPharma Co., Ltd. · Industry
Sex
Male
Age
20 Years – 50 Years
Healthy volunteers
Accepted

Summary

Clinical trial to evaluate the pharmacokinetic interactions and safety between telmisartan and chlorthalidone.

Conditions

Interventions

TypeNameDescription
DRUGTelmisartan 80mg
DRUGChlorthalidone 25mg

Timeline

Start date
2012-11-01
Primary completion
2013-06-01
Completion
2013-06-01
First posted
2013-03-07
Last updated
2014-02-25

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01806363. Inclusion in this directory is not an endorsement.